Testosterone therapy nearly halves mortality, CV event risks for opioid users

There may be mortality, musculoskeletal and cardiovascular benefits from testosterone therapy among men with low testosterone due to opioid use, according to findings published in JAMA Network Open. “Little is known about the effects of testosterone treatment on health outcomes in men with opioid-induced androgen deficiency (OPIAD), who often experience marked suppression of testosterone

Read the full article here

Related Articles